BridgeMD
New treatment option for Neuromuscular Blockade
Official title Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients
ClinicalTrials.gov ID: NCT05993390
What this study is testing
What is Sugammadex?
Sugammadex is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for neuromuscular blockade.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to compare the effect of use of reversal agents for neuromuscular blockade in critically ill patients on time for neurological assessment after endotracheal intubation The main questions it aims to answer are: The use of reversal agents for neuromuscular blockade after endotracheal intubation may reduce the time for neurological assessment. The types of reversal agents for neuromuscular blockade may affect the time for neurological assessment.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 90
You may be able to join if
- Adult patients 19 years of age or older who were intubated after admission to the intensive care unit.
You likely can't join if
- Patients younger than 19 years of age
- Patients who are not neurologically evaluable or have concomitant neurologic dysfunction
- Patients with neuromuscular disorder
- Patients with a history of drug allergic reactions to sugammadex or neostigmine
- Patients taking or planning to take toremifene, fusidic acid, or hormonal contraceptives
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, Jongno-gu, South Korea
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, Jongno-gu, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.